Stocks GWPH (GWPH | GW PHARMACEUTICALS PLC)
Stock quotes GW PHARMACEUTICALS PLC (GWPH) for today
Stock chart GWPH and quotes
Financial data GW Pharmaceuticals
GW PHARMACEUTICALS PLC revenues grew 22.07% in FY 2018 compared to FY 2017 to 12.74m. Net income fell 73.16% to -295.17m.
Information about the company GW Pharmaceuticals
GW Pharmaceuticals plc was founded in 1998 and is based in Cambridge, UK. It is a biopharmaceutical company, which is currently focused on developing and marketing cannabinoid-based medicines for a range of disease areas. Key products include Epidiolex, which is a liquid formulation of pure plant-derived cannabidiol (CBD), and Sativex (nabiximols), which is used for the treatment of spasticity due to multiple sclerosis (MS). The Company operates through three segments: Commercial, Sativex Research and Development, and Pipeline Research and Development. Follow the GWPH instrument to learn all about the latest news and developments.
Company statistics GW Pharmaceuticals
Sector: Healthcare
Industry: Biotechnology & Medical Research
Employees: 791
EN
ES
RU
DE